Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?
| Data(s) |
2011
|
|---|---|
| Identificador | |
| Publicador |
Informa Healthcare |
| Relação |
Doggrell, Sheila & Christensen, Anne-Marie (2011) Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Expert Opinion on Pharmacotherapy, 12(1), pp. 157-163. |
| Fonte |
Faculty of Science and Technology; Medical Sciences; Pharmacy |
| Palavras-Chave | #111500 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES #chronic myeloid leukaemia, clinical trials, dasatinib, imatinib, nilotinib |
| Tipo |
Journal Article |
